News

Shipments to China are now paused through the end of 2025, dragging global sales of the HPV vaccine down 55% last quarter.
Merck has characterized its cost-cutting initiative as more of a reallocation of resources to support other, higher-growth ...
Merck has launched a sweeping cost-cutting effort designed to save $3 billion annually by the end of 2027, the company said ...
With two molecules in mid-stage trials, the pharma giant is taking another swing at the difficult disease with a greater ...
Merck Q2 earnings beat estimates but revenue fell short. Gardasil sales dropped while Keytruda and other treatments drove ...
Along with its financial results for the second quarter of 2025, Merck revealed a restructuring plan to save $3 billion by ...
Merck said on Tuesday it was extending its pause on Gardasil shipments to China until at least the end of 2025 due to ...